Canadian Community Utilization of Stroke Prevention Study - Emergency Department (C-CUSP ED)
Atrial Fibrillation, Stroke
About this trial
This is an interventional prevention trial for Atrial Fibrillation focused on measuring Oral anticoagulant, Knowledge translation, Emergency department
Eligibility Criteria
Inclusion Criteria:
- Patients who present to the emergency department with electrocardiographically documented atrial fibrillation on a 12 lead ECG
Exclusion Criteria:
- Prosthetic or mechanical mitral or aortic valve
- Known rheumatic heart disease
- Unable to provide informed consent
- Will be admitted to hospital
- Life expectancy of < 6 months
- Metastatic malignancy
Sites / Locations
- Lions Gate Hospital
- Dr. Georges-L.-Dumont University Hospital Centre
- Dartmouth General Hospital
- Cobequid Community Health Centre
- Halifax Infirmary
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Other
Other
Phase 1: Retrospective Chart Review
Phase 2: Low-Intensity Intervention
Phase 3: High-Intensity Intervention
Retrospective chart review of all patients who presented to the emergency department (ED) with ECG-documented AF during 1 year prior to study commencement. The main purpose of Phase 1 is to determine if oral anticoagulants were prescribed for eligible AF patients at ED discharge.
Low-intensity intervention will be applied in the ED during 6 months, involving physician education, distribution of an AF patient education package, short-term oral anticoagulant prescription, and a follow-up letter to the patient's family physician.
Phase 3 incorporates the Phase 2 intervention, and adds immediate follow-up (within 48-72 hours) in a community AF clinic run by a nurse/pharmacist who is supervised by a specialist in AF.